Angiotensin-converting enzyme I/D polymorphism and diabetic peripheral neuropathy in type 2 diabetes mellitus: A meta-analysis
Background: Several molecular epidemiological studies have been conducted to examine the association between angiotensin-converting enzyme ( ACE ) I/D polymorphism and diabetic peripheral neuropathy (DPN) risk. However, the conclusions remained controversial. We therefore performed this meta-analysi...
Main Authors: | Yao Li, Nanwei Tong |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2015-12-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320314539828 |
Similar Items
-
Polymorphism of angiotensin-converting enzyme (rs4340) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus
by: Šeruga M, et al.
Published: (2016-12-01) -
Clinical and preclinical evidence that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prevent diabetic peripheral neuropathy
by: Shiori Iwane, et al.
Published: (2024-01-01) -
Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus
by: T. Yu. Poniatowskaya
Published: (2015-03-01) -
Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus
by: T. Yu. Poniatowskaya
Published: (2015-03-01) -
Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus
by: Bilge Volkan-Salanci, et al.
Published: (2009-03-01)